Press release
Pressure Ulcers Market is expected to reach USD 15.3 billion by 2034
Pressure Ulcers
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71431
Driven by demographic shifts, healthcare investments, and innovation in wound care solutions, the global pressure ulcers market is set for strong expansion. In 2024, the market size is valued at USD 6.2 billion, projected to reach USD 15.3 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.6% between 2025 and 2034.
This growth reflects the convergence of advanced wound care products, regenerative medicine, and preventive technologies, positioning pressure ulcer management as a critical area of healthcare innovation.
Market Overview
• Market Size (2024): USD 6.2 billion
• Forecasted Market Size (2034): USD 15.3 billion
• CAGR (2025-2034): 9.6%
• Key Drivers: Aging global population, rising chronic disease prevalence, increased hospital stays, and innovation in wound dressings and biologics.
• Key Challenges: High treatment costs, recurrence rates, underdiagnosis in homecare, and healthcare disparities in developing nations.
• Leading Players: Smith & Nephew plc, Mölnlycke Health Care, 3M Healthcare, Coloplast A/S, ConvaTec Group, Medtronic plc, Johnson & Johnson, B. Braun Melsungen AG, Integra LifeSciences, and Cardinal Health.
The market sits at the intersection of medical devices, pharmaceuticals, and home healthcare, reflecting its multi-dimensional nature.
Segmentation Analysis
The pressure ulcers market can be segmented by product, platform, technology, end use, and application.
By Product
• Advanced wound dressings (hydrocolloid, foam, alginate, film dressings)
• Negative pressure wound therapy (NPWT) devices
• Pressure-relieving devices (specialized beds, mattresses, cushions)
• Traditional wound care products (gauze, bandages)
• Biologics (growth factors, skin substitutes)
• Others (antimicrobial ointments, adjunctive therapies)
By Platform
• Pharmaceuticals (topical antibiotics, pain management, growth factors)
• Medical devices (NPWT systems, pressure-relieving beds)
• Biologics (skin substitutes, cell therapies)
• Combination products
By Technology
• Conventional wound care
• Regenerative medicine (stem-cell, tissue engineering)
• Advanced wound dressings with nanotechnology
• Digital wound monitoring and telehealth integration
By End Use
• Hospitals and specialty clinics
• Long-term care facilities
• Ambulatory surgical centers
• Homecare settings
• Academic and research institutions
By Application
• Stage I pressure ulcers (non-blanchable erythema)
• Stage II pressure ulcers (partial-thickness skin loss)
• Stage III pressure ulcers (full-thickness skin loss)
• Stage IV pressure ulcers (deep tissue damage)
• Others (unstageable, suspected deep tissue injuries)
Segmentation Summary
Advanced wound dressings and NPWT devices dominate the market, while biologics and regenerative therapies are gaining traction. Pressure-relieving devices represent a crucial preventive segment, especially in elderly care.
Explore Full Report here: https://exactitudeconsultancy.com/reports/71431/pressure-ulcers-market
Regional Analysis
North America
• Largest market with ~40% share in 2024.
• High prevalence of elderly populations and chronic diseases.
• Advanced healthcare infrastructure and adoption of NPWT and biologics.
• Strong presence of leading wound care companies.
Europe
• Accounts for ~30% of the global market.
• Germany, France, and the UK lead with advanced wound care adoption.
• Strong focus on preventive care and reimbursement support.
Asia-Pacific (APAC)
• Fastest-growing region with CAGR above 11%.
• Aging populations in Japan and China, and expanding healthcare infrastructure in India and Southeast Asia.
• Rising investments in wound care innovation and homecare devices.
Middle East & Africa (MEA)
• Smaller but steadily growing market.
• Gulf states investing in advanced wound care products.
• Limited access in lower-income regions remains a challenge.
Latin America
• Moderate growth led by Brazil and Mexico.
• Expanding healthcare systems and increased focus on homecare and long-term care.
Regional Summary
North America and Europe lead revenues, but Asia-Pacific is the key growth engine, driven by demographic changes, healthcare investments, and increasing access to advanced wound care solutions.
Market Dynamics
Key Growth Drivers
1. Aging Population: Rising global geriatric numbers increase immobility-related pressure ulcer risks.
2. Chronic Disease Burden: Diabetes, cardiovascular diseases, and obesity drive higher incidence rates.
3. Technological Innovation: Growth in NPWT, advanced dressings, and digital wound monitoring.
4. Preventive Healthcare Expansion: Demand for pressure-relieving beds and cushions.
5. Government and Reimbursement Policies: Support for advanced wound care in developed economies.
Key Challenges
1. High Costs of Advanced Therapies: Biologics and NPWT systems remain expensive.
2. Recurrence Rates: Many patients require repeated treatments.
3. Healthcare Inequalities: Limited access in low-income countries.
4. Shortage of Skilled Wound Care Specialists: Affects quality of management.
Latest Trends
• Regenerative Medicine: Skin substitutes, growth factors, and stem-cell therapies gaining momentum.
• Digital Health Tools: AI-powered wound assessment and telehealth platforms.
• Smart Dressings: Incorporating sensors to monitor healing progress.
• Homecare Expansion: Portable NPWT devices and advanced dressings for outpatient use.
• Sustainability: Eco-friendly materials in wound dressings gaining interest.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71431
Competitor Analysis
Major Players in the Pressure Ulcers Market:
• Smith & Nephew plc - Leading in advanced wound dressings and NPWT systems.
• Mölnlycke Health Care - Innovator in foam dressings and surgical solutions.
• 3M Healthcare - Strong portfolio of wound dressings and infection prevention.
• Coloplast A/S - Specialty in advanced wound care and continence products.
• ConvaTec Group - Notable for ostomy, continence, and wound management.
• Medtronic plc - Device innovations in wound care and prevention.
• Johnson & Johnson - Broad healthcare solutions, including wound management.
• B. Braun Melsungen AG - Expanding wound care and infection prevention.
• Integra LifeSciences - Leader in skin substitutes and regenerative wound care.
• Cardinal Health - Large-scale supplier of traditional and advanced wound care products.
Competitive Summary
The market is moderately consolidated, with Smith & Nephew, Mölnlycke, 3M, and Coloplast dominating advanced wound care. Integra and ConvaTec lead in biologics and NPWT, while Medtronic and J&J leverage global reach. Competition is intensifying with new entrants in regenerative and digital wound care.
Conclusion
The global pressure ulcers market is expected to grow from USD 6.2 billion in 2024 to USD 15.3 billion by 2034, at a CAGR of 9.6%.
• Advanced wound dressings and NPWT devices dominate today, while biologics and regenerative therapies represent the future.
• North America and Europe lead adoption, but Asia-Pacific is the fastest-growing region, fueled by aging populations and healthcare expansion.
• Challenges such as costs, recurrence, and unequal access underscore the need for broader adoption of preventive and patient-centered care.
In summary, the pressure ulcers market illustrates how aging demographics and technological innovation are reshaping wound care. Companies that combine advanced products, digital health, and accessibility strategies will lead the next decade of growth.
This report is also available in the following languages : Japanese (褥瘡市場), Korean (압박성 궤양 시장), Chinese (压疮市场), French (Marché des escarres), German (Markt für Druckgeschwüre), and Italian (Mercato delle ulcere da pressione), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71431/pressure-ulcers-market#request-a-sample
Our More Reports:
Duchenne Muscular Dystrophy Market
https://exactitudeconsultancy.com/reports/71651/duchenne-muscular-dystrophy-market
Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder Market
https://exactitudeconsultancy.com/reports/71649/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Alport Syndrome Market
https://exactitudeconsultancy.com/reports/71647/alport-syndrome-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pressure Ulcers Market is expected to reach USD 15.3 billion by 2034 here
News-ID: 4166609 • Views: …
More Releases from Exactitude Consultancy
Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction
Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk of arrhythmias, heart failure, and sudden cardiac death. Once managed primarily through beta-blockers, calcium channel blockers, and invasive procedures, the HCM treatment landscape has expanded with the approval of targeted therapies such as cardiac myosin inhibitors.
Growing awareness of genetic cardiovascular diseases, advances in molecular diagnostics,…
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction
Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance with stringent regulatory standards. To meet these demands, pharmaceutical and biotechnology companies are increasingly outsourcing to Contract Research Organizations (CROs) specializing in biologics.
Biologics CROs provide services spanning discovery, preclinical research, clinical trials, bioanalytical testing, and regulatory consulting. With the rise of biologics, biosimilars, and advanced…
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction
Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ dysfunction, and premature death. The condition is categorized into several subtypes (A, B, and C), each varying in severity and progression.
Historically, treatment has been limited to palliative and supportive care. However, the landscape is changing rapidly with the development of enzyme replacement therapies (ERT), substrate…
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of the unfolded protein response. PERK inhibitors are designed to modulate this pathway, reducing stress-induced cell death and playing a pivotal role in oncology, neurodegenerative research, and metabolic disorders. As precision medicine continues to gain traction, PERK inhibitors are attracting significant attention from both biotech firms…
More Releases for NPWT
NPWT Devices and Dressings Market Size 2024 to 2031.
Market Overview and Report Coverage
NPWT (Negative Pressure Wound Therapy) Devices and Dressings are used to promote wound healing by applying negative pressure to the wound site, removing excess fluid and promoting blood flow. These devices have gained popularity in recent years due to their effectiveness in wound care management.
The future outlook for the NPWT Devices and Dressings Market is promising, with a projected growth rate of 4.30% during…
Global Negative Pressure Wound Therapy (NPWT) Devices Market Size By Product (Si …
Negative Pressure Wound Therapy (NPWT) Devices Market Size And Forecast
Negative Pressure Wound Therapy (NPWT) Devices Market size was valued at USD 2.15 Billion in 2021 and is projected to reach USD 3.45 Billion by 2030, growing at a CAGR of 5.5% from 2023 to 2032.
A high rate of caesarean sections in elderly mothers, which results in an increase in post-operative use of NPWT devices, as well as other factors, are…
Automated Readers To Revitalize The Npwt Devices And Dressings Market
The US$ 1991.5 Mn global negative pressure wound therapy (NPWT) devices and dressings market is projected for promising growth over the next 10 years. The global sales of NPWT Devices And Dressings are likely to expand at a healthy CAGR of 7.1% and reach a value of over US$ 3963 Mn by the end of 2027.
According to Persistence Market Research, developing countries hold a greater growth potential, attributed to exploding…
Global Negative Pressure Wound Therapy (NPWT) Market Research Report
This report studies the global Negative Pressure Wound Therapy (NPWT) market status and forecast, categorizes the global Negative Pressure Wound Therapy (NPWT) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Atmos Inc. Innovative Therapies, Inc. Invacare Corporation Prospera Medline Industries Inc.…
Negative Pressure Wound Therapy (NPWT) Devices Market 2016-2020
SA-BRC announces the release of market assessment report on “Global Negative Pressure Wound Therapy (NPWT) Devices Market Assessment & Forecast: 2016-2020”.
Affordable rental and reimbursement for rental NPWT devices along with availability of single-use devices has propelled the homecare segment which is anticipated to grow the fastest with a CAGR of 7.1% between 2016 and 2020 according to the new report “Global Negative Pressure Wound Therapy (NPWT) Devices Market Assessment &…
Global NPWT Devices Market Professional Survey Report 2017
This report studies NPWT Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Acelity
Mlnlycke Health Care
4L Health
KCI
Smith & Nephew
Cardinal Health
Devon Medical
Paul Hartmann
Medela
BSN medical
Carilex Medical
ConvaTec
Equinoxo2 Medical
Galaxy Medical Products
Genadyne
H&R Healthcare
Innovative…
